Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor–Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

PURPOSE: To describe estradiol (E2), estrone (E1), and estrone sulfate (E1S) levels during the first year of monthly triptorelin plus exemestane or tamoxifen and to assess possible suboptimal suppression while receiving exemestane plus triptorelin. PATIENTS AND METHODS: Premenopausal patients with e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Bellet, Meritxell, Gray, Kathryn P., Francis, Prudence A., Láng, István, Ciruelos, Eva, Lluch, Ana, Climent, Miguel Angel, Catalán, Gustavo, Avella, Antoni, Bohn, Uriel, González-Martin, Antonio, Ferrer, Roser, Catalán, Roberto, Azaro, Analía, Rajasekaran, Agnita, Morales, Josefa, Vázquez, Josep, Fleming, Gini F., Price, Karen N., Regan, Meredith M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872316/
https://ncbi.nlm.nih.gov/pubmed/26729437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.61.2259
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados